Sandy Spring Bank Teva Pharmaceutical Industries LTD Transaction History

Sandy Spring Bank

  • $2.4 Billion
  • Q3 2024

A detailed history of Sandy Spring Bank transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sandy Spring Bank holds 500 shares of TEVA stock, worth $11,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$11,385
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
SELL
$10.67 - $14.43 $1,067 - $1,443
-100 Reduced 16.67%
500 $7,000
Q4 2023

Jan 26, 2024
BUY
$8.12 - $10.63 $811 - $1,063
100 Added 20.0%
600 $6,000
Q3 2022

Nov 02, 2022
BUY
$6.86 - $11.95 $3,430 - $5,975
500 New
500 $4,000
Q3 2020

Nov 09, 2020
SELL
$8.57 - $12.69 $2,571 - $3,807
-300 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$8.12 - $13.12 $1,623 - $2,624
200 Added 200.0%
300 $3,000
Q4 2018

Feb 08, 2019
SELL
$14.59 - $23.84 $6,244 - $10,203
-428 Reduced 81.06%
100 $2,000
Q3 2018

Nov 07, 2018
SELL
$21.06 - $25.65 $4,212 - $5,130
-200 Reduced 27.47%
528 $11,000
Q2 2018

Aug 03, 2018
SELL
$16.77 - $24.71 $6,791 - $10,007
-405 Reduced 35.75%
728 $17,000
Q1 2018

May 04, 2018
BUY
$16.68 - $22.07 $1,668 - $2,207
100 Added 9.68%
1,133 $20,000
Q4 2017

Feb 02, 2018
SELL
$11.23 - $19.1 $4,379 - $7,449
-390 Reduced 27.41%
1,033 $20,000
Q3 2017

Nov 03, 2017
SELL
$15.41 - $32.17 $471,638 - $984,595
-30,606 Reduced 95.56%
1,423 $25,000
Q2 2017

Aug 11, 2017
BUY
N/A
32,029
32,029 $1.08 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email